The UI College of Pharmacy has the pleasure of honoring several alumni and friends Oct. 24 during the Osterhaus Lifetime Achievement Symposium and Alumni Awards Ceremony. The recipients are exemplary representatives of the College’s alumni and friends who have excelled in their pharmacy practice, research, and community advancement, while simultaneously being steadfast ambassadors for the pharmacy profession and the College. The ceremony is part of the College’s Homecoming celebrations.
Osterhaus Medal for Lifetime Achievement Award
The Osterhaus Medal for Lifetime Achievement is presented annually to one or more individuals who have made extraordinary achievements in the pharmacy profession. This medal is a pinnacle award given by the UI College of Pharmacy to a recipient who has advanced the practice of pharmacy in profound ways or made significant strides in discovery.
Marilyn Osterhaus, '80 BSPh
Matthew C. Osterhaus, '80 BSPh
Marilyn Osterhaus is a community pharmacist who previously co-owned Osterhaus Pharmacy in Maquoketa, Iowa. She is an adjunct faculty member at the UI College of Pharmacy and Drake University College of Pharmacy & Health Sciences and serves as a preceptor for Community Care Pharmacy Practice residents and Doctor of Pharmacy students. Osterhaus is also an emeritus member of the UI College of Pharmacy Alumni Board.
Osterhaus’ practice centered on post mastectomy patients, specialty compounding, over-the-counter medication use, and encouraging the pharmacy practice advancement in the community setting. She is active in local, state, and national pharmacy associations. Her various leadership roles have included being a board member and honorary president of the Iowa Pharmacy Association (IPA) and Dubuque Area Pharmacists Association president. She is a recipient of the UI College of Pharmacy Distinguished Alumni Award, the AACP Crystal APPLE Award for Excellence in Experiential Education, and the 2019 IPA Bowl of Hygeia.
Osterhaus is extremely engaged in her local community, serving on numerous boards and committees, including the Jackson County Prevention Coalition, the Jackson County Historical Preservation Commission, and the Maquoketa Art Experience. She is married to fellow pharmacist Matthew Osterhaus, and they have four children: Andy, Maria, Jack, and Laura, and 11 grandchildren.
Matthew Osterhaus is a community pharmacist who previously co-owned Osterhaus Pharmacy in Maquoketa, Iowa. He is an adjunct faculty member at the UI College of Pharmacy and Drake University College of Pharmacy & Health Sciences and serves as a preceptor for Community Care Pharmacy Practice residents and Doctor of Pharmacy students. Osterhaus is also an emeritus member of the UI College of Pharmacy Executive Leadership Board.
Osterhaus was a founding investor of Outcomes and has been instrumental in furthering community-based research in Iowa. He has served on several state boards, committees, and commissions, including the Iowa Board of Pharmacy Examiners. Currently, Osterhaus is president of CPESN Iowa and national luminary of CPESN USA (Community Pharmacy Enhanced Services Network).
An active member of local, state, and national pharmacy associations, Osterhaus has held a variety of leadership positions, including president of the American Pharmacists Association (APhA) and the Iowa Pharmacy Association (IPA). His focus has been enhancing patient interaction of pharmacists by using technicians and technology, expanding community pharmacy residencies, leadership development, and the attainment of provider status for pharmacists. Osterhaus is a recipient of the UI College of Pharmacy Distinguished Alumni Award, APhA-APPM Distinguished Achievement Award in Community and Ambulatory Practice, and the APhA Good Government Pharmacist of the Year.
Osterhaus is highly involved in community development and currently serves on multiple area boards, including the Maquoketa Industrial Development Assistance Services and the Maquoketa Area YMCA Endowment Committee. He is married to fellow pharmacist Marilyn Osterhaus, and they have four children: Andy, Maria, Jack, and Laura, and 11 grandchildren.
Distinguished Alumni Award
The Distinguished Alumni Award is presented annually to individuals who have made illustrious contributions to the theory and practice of pharmacy or demonstrated major accomplishments in a professional pharmacy practice or pharmaceutical research and development.
Barry L. Carter, '78 BSPh, PharmD
Valerie E. Jensen, '90 BSPh
David W. Miller, '83 BSPh, PhD
An internationally recognized expert in hypertension and team-based care, Barry Carter has served on faculties at multiple universities, including the UI College of Pharmacy; University of Houston and Baylor College of Medicine; and the University of Colorado, where he was Department of Pharmacy Practice chair. Carter returned to the UI in 2000 and has since received more than $33 million in National Institutes of Health (NIH) funding as the principal investigator and another $43 million as a co-investigator.
Carter is past president of the American College of Clinical Pharmacy (ACCP). He has been named a fellow of the American Heart Association Council on High Blood Pressure Research, ACCP, and the American Society of Hypertension. Carter was a member of the National Heart, Lung, and Blood Institute’s Fifth, Sixth, Seventh, and Eighth Joint National Committees on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. He continues to collaborate with UI investigators on NIH grants involving hypertension management or cardiovascular disease.
Valerie Jensen is associate director of the Drug Shortage Staff at the U.S. Food and Drug Administration (FDA). She leads a dedicated team that has prevented hundreds of drug shortages throughout the years by working with the pharmaceutical industry and multiple stakeholders.
Upon her UI graduation, Jensen joined the U.S. Public Health Service (PHS) as a commissioned officer. Her first duty station was the Whiteriver Indian Hospital in Whiteriver, Arizona, where she completed a postgraduate year one (PGY1) residency in Ambulatory Care. Jensen transferred to the FDA in 1999 and was one of the initial developers of its Drug Shortage Program. She was promoted to the rank of captain in 2009.
Jensen was deployed by the U.S. PHS as a pharmacist to multiple national disaster events, including Hurricane Katrina where she was responsible for pharmacy services in temporary medical facilities. She retired from active duty after 30 years of service in July 2020 and was hired back into her same FDA position as a civilian one week later at the height of the pandemic. Jensen has thoroughly enjoyed precepting UI pharmacy students at the FDA.
David Miller built a career operating at the intersection of science, medicine, and economics. He currently is chair and chief executive officer of Genesis Research Group, a pharma services consultancy, and is an operating partner at GHO Capital. Miller began his career at Glaxo (now GSK) in pharmacoeconomics where he was hired by Jane Osterhaus, ’81 BSPh, PhD. He also has held executive roles at Elan and Biogen.
A sought-after advisor, mentor, and board member, Miller serves on boards at Eliquent; Aitia; Almaden Genomics; the University of Maryland, Baltimore (UMB) School of Pharmacy; and the UI College of Pharmacy (Executive Leadership Board). He previously sat on boards with the National Pharmaceutical Council, the University of California San Francisco School of Pharmacy, and the American Foundation for Pharmaceutical Education. Miller earned his PhD at UMB, studying health economics and policy.
He and his wife, Wendy, and their two sons, Trey and Grady, have made London, UK, their home for more than 20 years.
Honorary Alumni Award
The Honorary Alumni Award annually recognizes friends of the College for their personal contribution toward pharmacy achievement, leadership, and service to the profession, or for exhibiting exceptional service to the College. These individuals inspire our students and serve as role models.
Judith E. Domer, PhD
Timothy R. Franson, BS Pharm, MD
A graduate of Tusculum College in Greenville, Tennessee, Judith Domer is dean emerita of Graduate Studies and Research at Appalachian State University in Boone, North Carolina. After earning a BS in biology and chemistry, she received a microbiology and immunology PhD from Tulane University. It was there she met and married Floyd Domer, ’54 BSPh. Judith went on to become a professor and teach medical and graduate students for 28 years in the school’s microbiology and immunology department while researching the immunology of opportunistic fungal diseases. She later was appointed Graduate School associate dean and then acting vice chancellor for Graduate Studies at the Medical Center.
Judith was co-director and then director for a Tulane NIH Training Grant in medical mycology and a regular and ad-hoc member of several NIH Study Sections. She also served on a plethora of editorial boards, most notably Reviews of Clinical Microbiology – for which she was the founding mycology editor – and Infection and Immunity. Throughout her career, Judith was heavily involved in professional-service activities and received the 2021 Founders Distinguished Service Award from the American Society for Microbiology.
Judith and Floyd were both first-generation college students only able to graduate debt-free with the help of scholarships, assistantships, and part-time employment. Both believed success is a shared achievement, in that we stand on the shoulders of those who came before us, and we are obligated to provide the foundation, both educationally and, as we are able, financially, for those who succeed after we are gone.
Timothy Franson has extensive experience in early and late phase drug development relating to clinical, regulatory, quality, and associated disciplines for small molecule, biological, cell, and gene therapies. As principal of Faegre Drinker Consulting’s life sciences regulatory consulting practice, he has worked with more than 100 clients and more than 20 major product approvals. Franson spent most of his professional career with Eli Lilly and Co. (Lilly Research Laboratories), retiring as global vice president for Regulatory Affairs and Drug Safety in 2008. He oversaw Lilly’s regulatory submissions, including more than 25 major approvals, and regulatory compliance and policy matters.
Franson’s expertise has led to significant leadership roles, including testifying before Congress for several renewals of the Prescription Drug User Fee Act and serving as chair of the Critical Path Institute board of directors, of which he still is a member. He has been part of alma mater Drake University College of Pharmacy & Health Sciences’ National Advisory Committee and the American Association of Colleges of Pharmacy’s Pharmaceutical Education Advisory Committee. Franson’s success has earned him accolades and speaking invitations, among them the Lilly Chairman's Ovation Award.
Genesis Alumni Award
The College of Pharmacy honors graduates of the past 20 years who have achieved early distinction in their field. Nominees include those who have made considerable contributions to the theory and practice of pharmacy or have demonstrated major accomplishments in a professional pharmacy practice or pharmaceutical research and development. Recipients also have contributed exceptional service to their community, the College, the profession, or the public.
Jessica M. Frank, '07 PharmD
Yogita Krishnamachari, '11 PhD
Jessica Frank is an experienced health care executive with expertise in government programs, health care quality measures, value-based care, and account management. As senior vice president for RxAnte in Virginia, she is recognized as a subject matter expert in Medicare Star Ratings, value-based payment models, and medication therapy management. Frank has experience managing performance-based networks and developing clinical pharmacy solutions for health plans in all market segments within the managed-care industry.
After earning her Doctor of Pharmacy, Frank completed a Managed Care Pharmacy residency with Outcomes in West Des Moines, Iowa, and spent the next 14 years there in clinical services, operations, and business development. Among the industry boards and panels on which she has served are the Centers for Medicare and Medicaid Services MTM Technical Expert Panel, the National MTM Advisory Board, and IPA’s board of trustees.
Yogita Krishnamachari is a director in Sterile Product Development at Merck & Co., Inc. In this role, she is responsible for CMC leadership toward Merck’s large molecule portfolio spanning all biologics modalities. Krishnamachari is considered a domain expert in the development of drug device combination product development for subcutaneous administration of biologics and antibody drug conjugate development and product tech transfer and commercialization. She also has a strong niche in oncology product development. During her 12 years at Merck, Krishnamachari has advanced products from first-in-human to commercialization, assuming roles of increasing responsibility.
Krishnamachari has co-authored several publications and co-invented four patents, one stemming from her work at Iowa. She is active in the American Association of Pharmaceutical Scientists, previously serving as Sterile Product Community chair and currently sitting as chair of the IQ novel excipient working group. Krishnamachari is also a member of a cross-industry subcutaneous delivery consortium.
Mentoring junior scientists is something Krishnamachari strongly values and dedicates time toward, focused on sharing her product-development experience. Outside of work, she enjoys cooking, baking, and dancing while trying to keep up with her two energetic sons.